Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis
Table 4
Transplant patients who responded and those who did not.
Noncategorical variables
Improved
Did not improve
Mean
SE
Mean
SE
Age in years
41.5
4.4
51
7.3
0.193
Duration to treat in weeks
67.5
16.2
97.5
26.7
0.355
Followup duration in weeks
57.5
16.2
64.3
28.1
0.549
Categorical variables
Improved
Did not improve
%
%
Gender (3 missing data)
Male
6
37.5
3
42.86
0.809
Female
10
62.5
4
57.14
Dialysis duration (3 missing data)
< 4 years
16
94.12
3
50
0.014
= or > 4 years
1
5.88
3
50
Prior renal transplantation
Prior transplantation
4
21.05
1
14.29
0.698
No prior transplantation
15
78.95
6
85.71
Other treatments
Transplantation alone
8
42.11
1
14.29
0.186
Other treatment used
11
57.89
6
85.71
T1: patients who received no treatment other than dialysis. T2: patients who received NSF specific treatment other than renal transplantation. T3: patients who received only renal transplantation. T4: patients who received NSF specific treatment followed by renal transplantation. : number of patients. SE: standard error. : probability value.
